Validation of Plasma Proneurotensin as a Novel Biomarker for the Prediction of Incident Breast Cancer
Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-13-1200
Full Text
Open PDFAbstract
Available in full text
Date
June 12, 2014
Authors
Publisher
American Association for Cancer Research (AACR)